-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HIV-1-inhibitor-36
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2170506-18-8.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 2170506-18-8 |
| Description | HIV-1 inhibitor-36 (Compound 2) is a potent HIV-1. HIV-1 inhibitor-36 has the potential for further development as novel latency reversing agent. |
Product Information
| Synonyms | HIV-1 inhibitor-36|CHEMBL4552693|SCHEMBL21533448|BDBM50524889|HY-147553|CS-0513842 |
| Molecular Weight | 345.24 |
| Molecular Formula | C14H14Cl2N2O2S |
| Canonical SMILES | CC1=C(C=CC(=C1)OCCCC(=O)NC2=NC=C(S2)Cl)Cl |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 349 |
| Exact Mass | 344.0153043 |
| Target | HIV |
| XLogP3-AA | 4.4 |
